Filgrastim SD/01 is a new form of Filgrastim (r-metHuG-CSF) with sustained effective duration in vivo (Molineux et al. Exp Hemat 27,1999,1724). We have compared its ability with that of conventional Filgrastim to stimulate neutrophilia in normal and leukopenic mice. We have also measured the kinetics of neutrophil production in normal mice following stimulation with SD/01. SD/01 (1 g/kg) was injected iv to normal mice 3 d after injection of cyclophosphamide (200 mg/kg), and temozolamide (90 mg/kg). Subsequent WBCC and neutrophils were recorded daily. Conventional filgrastim was injected 2 × daily (125 mg/kg) for 3 d. For production kinetics, normal mice were injected with tritiated thymidine (3HTdR, 37KBq/g) 3 d after SD/01. Bone marrow cytospins (@ 1 h) and blood smears (@ 1 h to 7 d later) were autoradiographed. Differential cell and 3HTdR labelling indices were then counted. In normal mice, neutrophil counts increased 16 fold over 4 d. In leukopenic mice they increased from their 3 d nadir of 105/ml to 26 × 106/ml 4 d later. 3HTdR labelling of maturing granulocytic cells in the marrow was 50–100% higher than in non-stimulated mice. Labelled mature neutrophils peaked in the peripheral blood 24 h (compared to 3-4 d in normal animals) after injection of 3HTdR. Stimulation of neutrophil production by a single inoculum of SD/01 mirrors that of conventional G-CSF for which repeated injections over at least 3 d are necessary to maintain effective plasma levels. Analysis of the kinetics of granulocyte production shows accelerated proliferation in the marrow followed by rapid release into the peripheral blood of neutrophils with a normal peripheral half-life. We conclude that granulocytopoiesis is modulated by SD/01 in exactly the same way as the conventional formulation, and is considerably more manageable in its application.
Read full abstract